• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI in ischemic heart disease: expansion of the current capabilities with MR contrast.

作者信息

Higgins C B, Saeed M, Wendland M

机构信息

Department of Radiology, University of California, San Francisco 94143.

出版信息

Am J Card Imaging. 1991 Mar;5(1):38-50.

PMID:10147583
Abstract

Magnetic resonance imaging (MRI) has been used to identify acute and chronic myocardial infarctions and the complications of myocardial infarctions. Studies in animals have shown high accuracy in the quantification of the volume (mass) of acute myocardial infarctions. However, the role of MRI in ischemic heart disease has been limited by the inability to detect noninfarctional myocardial ischemia or to reliably indicate relative myocardial perfusion. Studies in animal models of various myocardial ischemic events have shown that these aims can be addressed using MR contrast media. The effect of MR contrast media on regional myocardial signal intensity is complex and determined by several factors, including: (1) the type of contrast medium; (2) the dose of the contrast medium; (3) the T1- or T2-weighting of the imaging sequence; and (4) the type of imaging technique applied (spin echo, gradient echo, or echoplanar). This article describes some of the potential applications of MR contrast media in ischemic heart disease and the several factors that interact to cause the regional myocardial signal alterations induced by MR contrast media.

摘要

相似文献

1
MRI in ischemic heart disease: expansion of the current capabilities with MR contrast.
Am J Card Imaging. 1991 Mar;5(1):38-50.
2
[Magnetic resonance tomography in myocardial ischemia: state of the art].
Rofo. 1996 Sep;165(3):216-26. doi: 10.1055/s-2007-1015746.
3
[Myocardial microcirculation in humans--new approaches using MRI].[人类心肌微循环——磁共振成像的新方法]
Herz. 2003 Mar;28(2):74-81. doi: 10.1007/s00059-003-2451-6.
4
Gd(ABE-DTTA)-enhanced cardiac MRI for the diagnosis of ischemic events in the heart.钆(ABE - DTTA)增强心脏磁共振成像用于诊断心脏缺血事件。
J Magn Reson Imaging. 2005 May;21(5):536-45. doi: 10.1002/jmri.20326.
5
Magnetic resonance imaging for ischemic heart disease.缺血性心脏病的磁共振成像
J Magn Reson Imaging. 2007 Jul;26(1):3-13. doi: 10.1002/jmri.20976.
6
MR evaluation of myocardial ischemia and infarction.
Top Magn Reson Imaging. 1995 Fall;7(4):218-31.
7
Preliminary evaluation of EVP 1001-1: a new cardiac-specific magnetic resonance contrast agent with kinetics suitable for steady-state imaging of the ischemic heart.
Invest Radiol. 2003 Oct;38(10):642-52. doi: 10.1097/01.rli.0000077057.88108.3f.
8
Intracoronary injection of contrast media maps the territory of the coronary artery: an MRI technique for assessing the effects of locally delivered angiogenic therapies.冠状动脉内注射造影剂可描绘冠状动脉的供血区域:一种用于评估局部递送血管生成疗法效果的磁共振成像技术。
Acad Radiol. 2008 Nov;15(11):1354-9. doi: 10.1016/j.acra.2008.09.002.
9
Usage of the T1 effect of an iron oxide contrast agent in an animal model to quantify myocardial blood flow by MRI.利用动物模型中铁氧化物造影剂的T1效应通过磁共振成像定量心肌血流量。
Eur J Radiol. 2007 May;62(2):247-56. doi: 10.1016/j.ejrad.2006.12.002. Epub 2006 Dec 22.
10
Cardiac MRI of ischemic heart disease at 3 T: potential and challenges.3T场强下缺血性心脏病的心脏磁共振成像:潜力与挑战
Eur J Radiol. 2008 Jan;65(1):15-28. doi: 10.1016/j.ejrad.2007.10.022.